chronic hepatitis C and a cirrhosis of the liver patient
Conditions
Interventions
I inspect Helicobacter pylori by a serum antibody method. It is omeprazole 20mg, amoxicillin 750mg, clarithromycin 400mg per day twice oral administration, one week for a Helicobacter pylori positiv
Sponsors
Hyogo College of Medicine hepatobiliary and pancreas internal medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.The patient of the chronic hepatitis C and cirrhosis of the liver 2.The patient that I understand the contents of this study, and an agreement of the study participation is provided from the person himself by a document
Exclusion criteria
Exclusion criteria: 1.The patient with a severe liver damage(Child-pugh classification GradeC) 2.In addition, the patient who judged the chief physician to be inappropriate as an object of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Examination according to the H.pylori cause of the disease factor seasonal polymorphism to have an influence on a change of the number of the blood platelets by the H.pylori sanitization medical treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| I divide blood platelet numerical value before sanitization into the high price group with low value group, and it is examined the number of the blood platelets improvement effect. The examination of the change of the blood platelet numerical value in the interferon dosage patient. Portal vein pressure sthenia symptom stomach symptom (PHG),an improvement effect of the gullet varication by the H.pylori sanitization medical treatment. | — |
Countries
Japan
Contacts
Public Contacttomoyuki takashima
hyogo college of medicine hepatobiliary and pancreas internal medicine
Outcome results
None listed